Intrinsiqq
Maia Biotechnology Inc. logo

Maia Biotechnology Inc. Insider Trading

MAIA

Compare
Last 12 months

Insiders bought $1.19M on the open market and sold nothing.

Net open-market
+$1.19M
21 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
7 / 0
executives and directors
Last open-market buy
Nov 2026
Nov 16, 2026

Get an email when MAIA's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Nov 13 – 16
    Stan Smith
    Director · bought 100,000 at avg $1.00
    100K
    6.6% of stake
  • Nov 13 – 16
    Vlad Vitoc
    Chief Executive Officer · bought 100,000 at avg $1.00
    100K
    7.9% of stake
  • Sep 14
    Vlad Vitoc
    Chief Executive Officer · bought 73,000 at $1.37
    100K
    6.2% of stake
  • Sep 10
    Ramiro Guerrero
    Director · bought 37,595 at $1.32
    50K
    5.1% of stake
  • Aug 26 – 28
    Ramiro Guerrero
    Director · bought 133,790 at avg $1.38
    184K
    22% of stake
  • Aug 24
    Ramiro Guerrero
    Director · bought 1,794 at $1.33
    2K
    0.3% of stake
  • Aug 20
    Ramiro Guerrero
    Director · bought 11,899 at $1.37
    16K
    2.0% of stake
  • Jun 1
    Vlad Vitoc
    Chief Executive Officer · bought 72,700 at $1.39
    101K
    6.5% of stake
  • Jun 1
    Stan Smith
    Director · bought 75,000 at $1.34
    101K
    5.2% of stake
  • Jun 1
    Sergei Gryaznov
    Chief Scientific Officer · bought 2,000 at $1.35
    3K
    4.5% of stake
  • Dec 22, 2025
    Stan Smith
    Director · bought 57,189 at $1.22
    70K
    4.2% of stake
  • Dec 22, 2025
    Steven M Chaouki
    Director · bought 40,849 at $1.22
    50K
    37% of stake
  • Dec 22, 2025
    Ngar Yee Louie
    Director · bought 81,699 at $1.22
    100K
    7.0% of stake
  • Dec 5, 2025
    Stan Smith
    Director · bought 13,740 at avg $1.20
    16K
    New position
  • Nov 26, 2025 – Nov 28, 2025
    Vlad Vitoc
    Chief Executive Officer · bought 72,000 at avg $1.11
    80K
    6.9% of stake
  • Nov 26, 2025 – Nov 28, 2025
    Cristian Luput
    Director · bought 38,145 at avg $1.09
    42K
    9.5% of stake
  • Nov 26, 2025
    Stan Smith
    Director · bought 15,000 at $1.04
    16K
    1.1% of stake
  • Nov 25, 2025
    Vlad Vitoc
    Chief Executive Officer · bought 10,500 at $0.97
    10K
    1.0% of stake
  • Nov 25, 2025
    Cristian Luput
    Director · bought 10,000 at $0.98
    10K
    2.6% of stake
  • Nov 24, 2025 – Nov 25, 2025
    Stan Smith
    Director · bought 25,000 at avg $0.98
    25K
    1.9% of stake
  • Nov 21, 2025 – Nov 24, 2025
    Vlad Vitoc
    Chief Executive Officer · bought 11,800 at avg $0.98
    12K
    1.2% of stake
  • Oct 1, 2025
    Stan Smith
    Director · bought 19,230 at $1.30
    25K
    1.5% of stake
  • Jun 3, 2025
    Stan Smith
    Director · bought 33,333 at $1.50
    50K
    2.6% of stake
  • May 8, 2025
    Ramiro Guerrero
    Director · bought 20,000 at $1.50
    30K
    3.5% of stake
  • May 8, 2025
    Stan Smith
    Director · bought 66,666 at $1.50
    100K
    5.5% of stake
  • Mar 3, 2025
    Ramiro Guerrero
    Director · bought 33,333 at $1.50
    50K
    6.2% of stake
  • Mar 3, 2025
    Stan Smith
    Director · bought 25,000 at $1.50
    38K
    2.1% of stake
  • Feb 24, 2025
    Stan Smith
    Director · bought 50,000 at $1.50
    75K
    4.4% of stake
  • Feb 24, 2025
    Ramiro Guerrero
    Director · bought 73,333 at $1.50
    110K
    16% of stake
  • Dec 13, 2024
    Stan Smith
    Director · bought 25,000 at $1.87
    47K
    2.3% of stake
  • Dec 13, 2024
    Ramiro Guerrero
    Director · bought 53,418 at $1.87
    100K
    12% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch MAIA, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with MAIA

CompareIntrinsic value
RANIRani Therapeutics Holdings Inc.
$0.51-12.03%10
AVIRAtea Pharmaceuticals Inc.
$3.96+0.76%40
IBOImpact Biomedical Inc.
$6.17+25.66%35
HROWHarrow Inc.
$30.41-5.35%15
SIGASiga Technologies Inc.
$2.40-9.43%24
XENEXenon Pharmaceuticals Inc.
$37.04-1.38%10
PRAXPraxis Precision Medicines Inc.
$300.43-3.37%10
CATXPerspective Therapeutics Inc.
$0.75-3.85%10

Held by ETFs

MAIA is in 1 US ETF. The largest of them, with MAIA's weight in each:

Spot a number that looks wrong? Check it in MAIA's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing MAIA

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.